{"disease":{"id":"encephalitis","name":"encephalitis"},"drugs":{"marketed":[{"drug_id":"acyclovir-sodium","indication_name":"Herpes Simplex Encephalitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"ACYCLOVIR SODIUM","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":35,"revenue":null,"mechanism":null},{"drug_id":"sulfadiazine","indication_name":"Encephalitis due to Toxoplasmosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Sulfadiazine","generic_name":"SULFADIAZINE","company_name":"Eli Lilly","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 2A","drug_class":"Sulfonamide Antibacterial [EPC]","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"hospital-based-vaccination-pathway","indication_name":"Japanese encephalitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hospital-Based Vaccination Pathway","generic_name":"hospital-based-vaccination-pathway","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"various pathogens","drug_class":"vaccine","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"hospital-based-vaccination-pathway","indication_name":"Japanese encephalitis (JE)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hospital-Based Vaccination Pathway","generic_name":"hospital-based-vaccination-pathway","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"various pathogens","drug_class":"vaccine","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"hospital-based-vaccination-pathway","indication_name":"Japanese encephalitis (JE) booster","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hospital-Based Vaccination Pathway","generic_name":"hospital-based-vaccination-pathway","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"various pathogens","drug_class":"vaccine","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"aciclovir","indication_name":"Encephalitis due to Herpesvirus","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Aciclovir","company_name":"Assistance Publique Hopitaux De Marseille","drug_phase":"marketed","molecular_target":"Purine nucleoside phosphorylase, DNA polymerase catalytic subunit, Purine nucleoside phosphorylase","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"acyclovir","indication_name":"Encephalitis due to Herpesvirus","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Zovirax","generic_name":"ACYCLOVIR","company_name":"Ligand Pharms","drug_phase":"marketed","molecular_target":"Purine nucleoside phosphorylase","drug_class":"Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]","quality_score":80,"revenue":null,"mechanism":"Acyclovir works by mimicking a building block of DNA to prevent the herpes virus from replicating."},{"drug_id":"foscarnet","indication_name":"Encephalitis caused by human herpesvirus 6 infection","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Foscavir","generic_name":"FOSCARNET","company_name":"Clinigen Hlthcare","drug_phase":"marketed","molecular_target":"","drug_class":"Pyrophosphate Analog DNA Polymerase Inhibitor","quality_score":75,"revenue":null,"mechanism":"Foscarnet works by directly inhibiting viral DNA polymerase, preventing the replication of viral DNA."},{"drug_id":"acyc","indication_name":"Encephalitis due to Herpesvirus","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"ACYC","company_name":"Ligand Pharms","drug_phase":"marketed","molecular_target":"Purine nucleoside phosphorylase, DNA polymerase catalytic subunit, Purine nucleoside phosphorylase","drug_class":"","quality_score":null,"revenue":null,"mechanism":"Acyc works by binding to a specific target in the body, although its exact mechanism is unknown."}],"pipeline":[],"offLabel":[],"totalMarketed":9,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06372665","title":"Safety Observation of the Japanese Encephalitis Vaccine Given With a Primary Immunization","phase":"","overall_status":"COMPLETED","enrollment_count":15357,"lead_sponsor_name":"Liaoning Chengda Biotechnology CO., LTD","has_results":false},{"nct_id":"NCT07358910","title":"Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Institut Pasteur du Cambodge","has_results":false},{"nct_id":"NCT04806620","title":"Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Brain Inflammation Collaborative","has_results":false},{"nct_id":"NCT06443333","title":"National, Multicentric Registry Study on Neuroimmunological Diseases in China","phase":"","overall_status":"RECRUITING","enrollment_count":7000,"lead_sponsor_name":"Xuanwu Hospital, Beijing","has_results":false},{"nct_id":"NCT04055766","title":"A Diagnostic Test on DeepDoc-an AI-based Decision Support System","phase":"","overall_status":"UNKNOWN","enrollment_count":4000,"lead_sponsor_name":"Xijing Hospital","has_results":false},{"nct_id":"NCT05198661","title":"Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis Collection","phase":"NA","overall_status":"RECRUITING","enrollment_count":3500,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT05414890","title":"Sensitivity and Specificity of TSA-CBA for Autoantibodies Against Neural Antigen Determination","phase":"","overall_status":"UNKNOWN","enrollment_count":2500,"lead_sponsor_name":"Beijing Tiantan Hospital","has_results":false},{"nct_id":"NCT04190303","title":"BIGlobal Intervention Study: Improving Diagnosis and Management of Suspected Brain Infections Globally","phase":"","overall_status":"COMPLETED","enrollment_count":2233,"lead_sponsor_name":"University of Liverpool","has_results":false},{"nct_id":"NCT03418441","title":"Central Nervous System Infections in Denmark","phase":"","overall_status":"RECRUITING","enrollment_count":1900,"lead_sponsor_name":"Aalborg University Hospital","has_results":false},{"nct_id":"NCT07333196","title":"Tongji NADs Cohort","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":1550,"lead_sponsor_name":"Tongji Hospital","has_results":false},{"nct_id":"NCT05155553","title":"QIAstat-Dx® Meningitis/Encephalitis Panel Performance Evaluation Study","phase":"","overall_status":"COMPLETED","enrollment_count":1524,"lead_sponsor_name":"QIAGEN Gaithersburg, Inc","has_results":false},{"nct_id":"NCT04094818","title":"TriVerity in the Diagnosis and Prognosis of Emergency Department Patients With Suspected Infections and Suspected Sepsis","phase":"","overall_status":"COMPLETED","enrollment_count":1441,"lead_sponsor_name":"Inflammatix","has_results":false},{"nct_id":"NCT06849011","title":"Inflammatory and Metabolic Prognostic Assessment in Critically Ill Neurological Patients","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":1185,"lead_sponsor_name":"Yan Zhang","has_results":false},{"nct_id":"NCT04223037","title":"Purified Inactivated Japanese Encephalitis Vaccine","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":1050,"lead_sponsor_name":"Chinese Academy of Medical Sciences","has_results":false},{"nct_id":"NCT06697678","title":"Risk Prediction Model for Severe Autoimmune Encephalitis","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Xuanwu Hospital, Beijing","has_results":false},{"nct_id":"NCT05941546","title":"Tick-borne Encephalitis Virus Research in Limousin","phase":"","overall_status":"COMPLETED","enrollment_count":878,"lead_sponsor_name":"University Hospital, Limoges","has_results":false},{"nct_id":"NCT04089436","title":"SouthEast Asia Encephalitis Project","phase":"","overall_status":"UNKNOWN","enrollment_count":800,"lead_sponsor_name":"Institut Pasteur","has_results":false},{"nct_id":"NCT04722328","title":"Establishment of Prevention and Control System of Central Nervous System Infection","phase":"","overall_status":"UNKNOWN","enrollment_count":715,"lead_sponsor_name":"Xuanwu Hospital, Beijing","has_results":false},{"nct_id":"NCT06023160","title":"Predicting Functional Outcome and Response to Therapy of Anti-NMDAR Encephalitis at Diagnosis","phase":"","overall_status":"COMPLETED","enrollment_count":714,"lead_sponsor_name":"Erasmus Medical Center","has_results":false},{"nct_id":"NCT04817917","title":"Seroprevalence of Neutralizing Antibodies Against Japanese Encephalitis Virus Among 6 Years Old Children With 5 Different Immunization Strategies in Zhejiang Province","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":712,"lead_sponsor_name":"Zhejiang Provincial Center for Disease Control and Prevention","has_results":false},{"nct_id":"NCT04823728","title":"HLA Analysis in Autoimmune Encephalitis and Related Disorders: Part II","phase":"","overall_status":"UNKNOWN","enrollment_count":700,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT03958058","title":"Tick-borne Encephalitis and Possible Borrelial Serology","phase":"","overall_status":"COMPLETED","enrollment_count":690,"lead_sponsor_name":"University Medical Centre Ljubljana","has_results":false},{"nct_id":"NCT03282370","title":"Evaluate Safety and Immunogenicity of a Vero Cell-Derived JE Vaccine in 9-24 Months of Age Children in Vietnam","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":655,"lead_sponsor_name":"National Institute of Hygiene and Epidemiology, Vietnam","has_results":false},{"nct_id":"NCT02880865","title":"Immunogenicity and Safety of Japanese Encephalitis Vaccine When Given With Measles-Mumps-Rubella (MMR) Vaccine","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":628,"lead_sponsor_name":"PATH","has_results":true},{"nct_id":"NCT03957616","title":"Incidence of Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis","phase":"","overall_status":"UNKNOWN","enrollment_count":600,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT06825312","title":"Immunogenicity, Safety, and Antibody Persistence of Different Immunization Strategies Against Japanese Encephalitis","phase":"PHASE4","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":600,"lead_sponsor_name":"Liaoning Chengda Biotechnology CO., LTD","has_results":false},{"nct_id":"NCT00249769","title":"Determining Safety and Efficacy of Japanese Encephalitis Vaccine When Given With Measles Vaccine","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":600,"lead_sponsor_name":"PATH","has_results":true},{"nct_id":"NCT03144570","title":"EURopean Study on Encephalitis in Intensive CAre","phase":"","overall_status":"COMPLETED","enrollment_count":596,"lead_sponsor_name":"ICUREsearch","has_results":false},{"nct_id":"NCT01001988","title":"Long-term Follow-up of Immunogenicity of a Single Dose of Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in Toddlers","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":596,"lead_sponsor_name":"Sanofi Pasteur, a Sanofi Company","has_results":true},{"nct_id":"NCT05092438","title":"QIAstat-Dx® Meningitis/Encephalitis Panel Performance Evaluation Study 001","phase":"","overall_status":"COMPLETED","enrollment_count":595,"lead_sponsor_name":"QIAGEN Gaithersburg, Inc","has_results":false},{"nct_id":"NCT03206541","title":"Neurologic Manifestations of the Arbovirus Infection in Colombia","phase":"","overall_status":"COMPLETED","enrollment_count":570,"lead_sponsor_name":"Johns Hopkins University","has_results":false},{"nct_id":"NCT02514746","title":"Long-term Immunogenicity After Receipt of JE Vaccine and Antibody Response and Safety to a Booster Dose","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":561,"lead_sponsor_name":"PATH","has_results":true},{"nct_id":"NCT05422664","title":"Acute Sympotomatic Seizure Secondary to Autoimmune Encephalitis and Autoimmune-associated Epilepsy","phase":"","overall_status":"UNKNOWN","enrollment_count":500,"lead_sponsor_name":"Liu Yonghong","has_results":false},{"nct_id":"NCT05017142","title":"Swiss Pediatric Inflammatory Brain Disease Registry (Swiss-Ped-IBrainD)","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"University of Bern","has_results":false},{"nct_id":"NCT05607394","title":"Prevalence of Tick-borne Encephalitis in the Pediatric Population Treated at the HUS and Characterization of Confirmed Pediatric Cases","phase":"","overall_status":"UNKNOWN","enrollment_count":500,"lead_sponsor_name":"University Hospital, Strasbourg, France","has_results":false},{"nct_id":"NCT02856451","title":"Risk Factors and Outcomes of Immune-Mediated Encephalitis Following Exposure to Nivolumab","phase":"","overall_status":"COMPLETED","enrollment_count":486,"lead_sponsor_name":"Bristol-Myers Squibb","has_results":false},{"nct_id":"NCT04946682","title":"Optimal Encephalitis/Meningitis Roadmap Via Precise Diagnosis and Treatment","phase":"NA","overall_status":"UNKNOWN","enrollment_count":484,"lead_sponsor_name":"Wen-hong Zhang","has_results":false},{"nct_id":"NCT01190228","title":"Study of Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in Children Previously Immunized With JE-CV","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":454,"lead_sponsor_name":"Sanofi Pasteur, a Sanofi Company","has_results":true},{"nct_id":"NCT05370573","title":"Brazil ICU Encephalitis Surveillance","phase":"","overall_status":"COMPLETED","enrollment_count":451,"lead_sponsor_name":"D'Or Institute for Research and Education","has_results":false},{"nct_id":"NCT06331702","title":"Immunogenicity of Japanese Encephalitis Vaccine Co-administered With Measles-Mumps-Rubella Vaccine (MMR)","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":408,"lead_sponsor_name":"Liaoning Chengda Biotechnology CO., LTD","has_results":false},{"nct_id":"NCT06680128","title":"A Study to Assess the Safety, Reactogenicity, and Immunogenicity of SK Japanese Encephalitis Messenger Ribonucleic Acid (mRNA) Vaccines (GBP560) in Healthy Adults","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":402,"lead_sponsor_name":"SK Bioscience Co., Ltd.","has_results":false},{"nct_id":"NCT05738668","title":"Clinical-immunological Features of Anti-NMDAR Encephalitis","phase":"","overall_status":"UNKNOWN","enrollment_count":400,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT05953974","title":"Validation of a Diagnostic Score for Encephalitis to Assess the Risk of Autoimmune Origin","phase":"","overall_status":"UNKNOWN","enrollment_count":350,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT02906631","title":"Epidemiology and Prognosis of Encephalitis in Intensive Care","phase":"","overall_status":"COMPLETED","enrollment_count":350,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT05746624","title":"Procedural Motor Memory in Long COVID-19","phase":"","overall_status":"COMPLETED","enrollment_count":333,"lead_sponsor_name":"National Institute of Neurological Disorders and Stroke (NINDS)","has_results":false},{"nct_id":"NCT06593249","title":"Management of Tick-borne Encephalitis","phase":"","overall_status":"COMPLETED","enrollment_count":318,"lead_sponsor_name":"University Medical Centre Ljubljana","has_results":false},{"nct_id":"NCT00463476","title":"Boosterability of Live Attenuated Japanese Encephalitis (JE) Vaccine in Children Who Have Previously Received Inactivated JE Vaccine","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":305,"lead_sponsor_name":"PATH","has_results":true},{"nct_id":"NCT00840801","title":"Immunogenicity, Safety and Interchangeability of Two Tbe Vaccines Administered According to a Conventional Schedule in Children","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":302,"lead_sponsor_name":"Pfizer","has_results":true},{"nct_id":"NCT06388161","title":"Neural Autoantibody Prevalence in New-onset Focal Seizures of Unknown Etiology","phase":"","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"Shen Chun-Hong","has_results":false},{"nct_id":"NCT07036042","title":"Clinical Characteristics of Patients With Anti-Collapsin Response Mediator Protein 2 Antibodies in Encephalitis or Encephalomyelitis","phase":"","overall_status":"COMPLETED","enrollment_count":300,"lead_sponsor_name":"Nanfang Hospital, Southern Medical University","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}